| ALMIRALL S.A. | 11.0000 / +0.92% |
| Date/Time | 04/09 / 17:35 |
| Chg. / Chg.(%) | 0.1000 / +0.92% |
| Bid | 10.8000 / 46 |
| Ask | 11.0900 / 225 |
| Open | 11.0600 |
| Previous Close | 10.9000 |
| High | 11.2500 |
| Low | 10.9000 |
| Volume [EUR] | 1,332,019.5400 |
| Volume [Units] | 120,282 |
| Price fixings | 329 |
| ISIN | ES0157097017 |
| Security | ALM |
| Exchange | Madrid |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Madrid | 11.0000 |  |
120,282 |
| Cboe Europe .. | 10.99 | |
43,506 |
| Cboe Europe .. | 10.92 | |
12,775 |
| Turquoise | 10.97 | |
7,013 |
| London Inter.. | 10.98 | |
1,910 |
| Frankfurt | 10.9100 | |
0 |
| Berlin | 10.800 |  |
0 |
| Stuttgart | 11.050 |  |
0 |
| Lang & Schwa.. | 10.880 | |
|
| TradeGate | 11.26 | 45 | |
| Nasdaq Other.. | 10.0500 | 9,581 |
News
- Paratek Pharmaceuticals Announces Initiation of Funding from BARDA for All FDA Required Post-marketing Studies for NUZYRA• (omadacycline)
04/02/2020 / 14:00 - GlobeNewswire - Paratek Pharmaceuticals Announces Initiation of Funding from BARDA for Security Requirements and U.S. Onshoring of the Manufacturing Supply Chain for NUZYRA• (omadacycline)
04/01/2020 / 14:00 - GlobeNewswire - ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
03/18/2020 / 10:18 - GlobeNewswire - Vectura Group plc: 2019 Preliminary Results
03/17/2020 / 13:00 - GlobeNewswire - Paratek Pharmaceuticals Announces the Submission of the pre-Emergency Use Authorization Application to the FDA for NUZYRA• (omadacycline)
03/10/2020 / 21:01 - GlobeNewswire
Real-time